CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

OBJECTIVES: Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse (®) technology in...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Valdecasas Gayo, Sonsoles, Ruiz-Alvarez, Maria Jesus, Gonzalez-Gay, Daniel, Ramos-Corral, Raquel, Marquez-Lietor, Eva, Del Amo, Nazaret, Plata, Maria del Carmen, Guillén-Santos, Raquel, Arribas, Ignacio, Cava-Valenciano, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197668/
https://www.ncbi.nlm.nih.gov/pubmed/37360615
http://dx.doi.org/10.1515/almed-2020-0005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197668/
https://www.ncbi.nlm.nih.gov/pubmed/37360615
http://dx.doi.org/10.1515/almed-2020-0005

Ejemplares similares